The Centers for Medicare and Medicaid Services (CMS) sent letters to every state Medicaid agency providing data the agency has reviewed relating to call center operations, unwinding renewal outcomes on terminations for procedural reasons and modified adjusted gross income (MAGI) application processing times.
The move from the CMS comes amid concerns that states have not done enough to prevent improper terminations of eligible Medicaid beneficiaries. The letter comes as states have been going through the process of redetermination of eligible Medicaid beneficiaries since April.
Emergency provisions during the COVID-19 pandemic had placed a moratorium on the redeterminations—leading to a record high 83.5 million people who were covered under Medicaid.
According to KFF data tracker, at least 4.1 million Medicaid enrollees have lost coverage as of August 9, 2023, based on the most current data from 42 states and the District of Columbia. Further, across all states with available data, 75 percent of all people disenrolled had their coverage terminated for procedural reasons. At this time, 28 state Medicaid programs provide some degree of adult hearing aid coverage although the extent of the coverage varies widely.
Reference
Center on Budget and Policy Priorities. (2023) Unwinding Watch: Tracking Medicaid Coverage as Pandemic Protections End (accessed August 14, 2023).
Recent Posts
Updated CPT® Codes Released for Vestibular Assessment
The American Medical Association (AMA) recently released the Current Procedural Terminology (CPT®) 2027 code book that includes the numbers for the four new vestibular assessment…
Mental Health Treatment by Adults in the United States
Some of our adult patients may have a comorbid diagnosis of a mental, behavioral, or emotional disorder. Of these patients, some may have sought and/or…
Cortical Changes in Total and Partial Vestibular Dysfunction, As Measured by EEG
Study Supports Expanded Candidacy for Pediatric Cochlear Implantation For children less than two years of age, current Food and Drug Administration (FDA) candidacy criteria for…



